Group items tagged

The right to healthcare requires ensuring that appropriate physical health services are available without discrimination and are accessible, acceptable and of good quality. Medico legal case (MLC) is a case where besides the medical treatment; police investigations are essential to fix the responsibility regarding the present condition of the patient.

'Digital' has become an important part of the everyday life. Digital healthcare plays a key role in the overall business strategy, and is going to change the world dramatically, affecting all businesses and modes of life.

The current global scenario recognizes regulatory medical writing as a tool to for developing authenticated documents related to products undergoing clinical trial. The purpose of regulatory medical writing is to offer the highest quality scientific documents for fulfilling the requirements of particular audience.

The last decade has seen a tremendous transformation in the medical space with information technology (IT) been a major facilitator for this change. With the advent of advanced medical devices and equipment, healthcare has become one of the most technologically spontaneous fields in the current times.

Medical writing is the process of writing scientific or regulatory document by specialized writers known as the "medical writers". Medical writers might not be the real scientists who did the authentic research, but work with the physicians / scientists concerned in the creation of data, and thereby assist to present that data in appropriate and clear way.

Clinical trials generate an extensive amount of statistical data. With the increasing complexity of segregated data collection, it is imperative to have an effective system to manage and to statistically analyse the data to produce end result. Clinical data management system (CDMS) is used for this purpose.

Medical-marketing or pharma-marketing is a term used for implementing the advertising strategies by pharmaceutical/biotech/medical device organizations for the promotion of their brands and products and meet the sales target. Besides, it also helps to regularly update the pharma-healthcare professionals about safe and effective use of the new drugs and devices available in the market.

The current competitive environment demands tactful management of most respected and skilled physicians by the healthcare organisations. Hence each healthcare organisation is making an ardent effort to ensure that no stone remains untouched. The fact of matter is not only true for the health care industry, but also for pharmaceutical companies.

Medical Affairs has originally emerged as a reaction because of increasing pressure from regulators to separate medical and commercial functions. Companies have been experiencing increasing internal demand to focus on generation and development of new products rather than managing products after FDA approval.

As soon as a potential moiety is identified it is subjected to pre-clinical studies for determination of safety, efficacy, pharmacokinetic and pharmacodynamic profiles of molecule which are later extrapolated to human volunteers or clinical subjects under clinical research. Clinical research is carried out meticulously at academic blocks, healthcare organizations and research study centers affiliated by regulatory bodies.

Gain weight technique is standard, however gain height? Extraordinary! If you are one among the short individuals who eager to induce taller at least 2 Inch from your height currently, you're in the correct track. Getting taller means anything to everyone. You gain respects from others, no a lot of rejection from the alternative sex, and your boss can even promote you since you have a nice posture of turning into a manager. So what you thing..?

Immuneering has entered into an agreement to expand its existing relationship with Bristol-Myers Squibb (BMS) for the use of Immuneering's proprietary computational biology methods to identify biological insights that would help in the discovery and development of medicines.

Germany-based OctreoPharm Sciences has received Orphan Drug Designation from the European Medicines Agency (EMA) for OPS202 as a diagnostic agent for the management of patients with gastro-entero-pancreatic-neuroendocrine tumors

PBR Staff Writer Published 24 February 2014 US-based biotechnology firm Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Application (sNDA) of its Kalydeco (ivacaftor) for the treatment of people with cystic fibrosis (CF).